Description
What is Tesamorelin?
Tesamorelin is a prescription growth-hormone-releasing hormone (GHRH) analog designed to naturally stimulate your pituitary gland to produce growth hormone in pulses. This distinct mechanism makes it a unique solution for targeted applications, especially for adults dealing with HIV-associated lipodystrophy.
Core Benefits and FDA Approval
Approved by the FDA under the brand name Egrifta, Tesamorelin is specifically effective in reducing metabolically active visceral adipose tissue—deep belly fat surrounding the internal organs. Unlike direct growth hormone injections, this solution works within your body’s natural framework for hormone secretion.
Exploration of Off-Label Uses
While its primary application targets visceral fat reduction in HIV-associated lipodystrophy, clinicians sometimes explore Tesamorelin for off-label uses like improving overall body composition, preserving lean muscle mass, or even supporting cognitive functions. Please note that it is not approved for general weight loss, and this product is strictly for research purposes only—
NOT INTENDED FOR HUMAN OR VETERINARY USE.
Reviews
There are no reviews yet.